These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25922146)

  • 1. Benefit of primary tumor resection in stage IV colorectal cancer with unresectable metastasis: a multicenter retrospective study using a propensity score analysis.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2015 Jun; 30(6):807-12. PubMed ID: 25922146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study.
    Ishihara S; Hayama T; Yamada H; Nozawa K; Matsuda K; Miyata H; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Ann Surg Oncol; 2014 Sep; 21(9):2949-55. PubMed ID: 24763981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database.
    Furuhata T; Okita K; Nishidate T; Hirata K; Ohnishi H; Kobayashi H; Kotake K; Sugihara K;
    Int J Clin Oncol; 2015 Oct; 20(5):922-7. PubMed ID: 25762168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.
    Zhang RX; Ma WJ; Gu YT; Zhang TQ; Huang ZM; Lu ZH; Gu YK
    World J Surg Oncol; 2017 Jul; 15(1):138. PubMed ID: 28750680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.
    Dorajoo SR; Tan WJ; Koo SX; Tan WS; Chew MH; Tang CL; Wee HL; Yap CW
    Int J Colorectal Dis; 2016 Feb; 31(2):235-45. PubMed ID: 26490055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.
    Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution.
    Sudo M; Furuya S; Shimizu H; Nakata Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
    World J Surg Oncol; 2019 Mar; 17(1):56. PubMed ID: 30904026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis.
    Tarantino I; Warschkow R; Worni M; Cerny T; Ulrich A; Schmied BM; Güller U
    Ann Surg; 2015 Jul; 262(1):112-20. PubMed ID: 25373464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Shida D; Hamaguchi T; Ochiai H; Tsukamoto S; Takashima A; Boku N; Kanemitsu Y
    Ann Surg Oncol; 2016 Oct; 23(11):3602-3608. PubMed ID: 27272107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Int J Surg; 2014; 12(9):925-30. PubMed ID: 25091400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
    't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
    Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients.
    Gresham G; Renouf DJ; Chan M; Kennecke HF; Lim HJ; Brown C; Cheung WY
    Ann Surg Oncol; 2014 Nov; 21(12):3917-23. PubMed ID: 24859937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
    Huang SH; Tsai WS; You JF; Hung HY; Yeh CY; Hsieh PS; Chiang SF; Lai CC; Chiang JM; Tang R; Chen JS
    Ann Surg Oncol; 2019 Jun; 26(6):1685-1694. PubMed ID: 30915591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
    Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
    Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.